13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Circulating DNA in plasma has many diagnostic applications, including noninvasive prenatal testing and cancer liquid biopsy. Plasma DNA consists of short fragments of DNA. However, there is little information about mechanisms that are involved in the fragmentation of plasma DNA. We showed that mice in which Dnase1l3 had been deleted showed aberrations in the fragmentation of plasma DNA. We also observed a change in the ranked frequencies of end motifs of plasma DNA caused by the Dnase1l3 deletion. In Dnase1l3 −/− mice pregnant with Dnase1l3 +/− fetuses, we observed a partial reversal of the plasma DNA aberrations. This study has thus linked the fields of nuclease biology and circulating nucleic acids and has opened up avenues for future research.

          Abstract

          Circulating DNA in plasma consists of short DNA fragments. The biological processes generating such fragments are not well understood. DNASE1L3 is a secreted DNASE1-like nuclease capable of digesting DNA in chromatin, and its absence causes anti-DNA responses and autoimmunity in humans and mice. We found that the deletion of Dnase1l3 in mice resulted in aberrations in the fragmentation of plasma DNA. Such aberrations included an increase in short DNA molecules below 120 bp, which was positively correlated with anti-DNA antibody levels. We also observed an increase in long, multinucleosomal DNA molecules and decreased frequencies of the most common end motifs found in plasma DNA. These aberrations were independent of anti-DNA response, suggesting that they represented a primary effect of DNASE1L3 loss. Pregnant Dnase1l3 −/− mice carrying Dnase1l3 +/− fetuses showed a partial restoration of normal frequencies of plasma DNA end motifs, suggesting that DNASE1L3 from Dnase1l3-proficient fetuses could enter maternal systemic circulation and affect both fetal and maternal DNA fragmentation in a systemic as well as local manner. However, the observed shortening of circulating fetal DNA relative to maternal DNA was not affected by the deletion of Dnase1l3. Collectively, our findings demonstrate that DNASE1L3 plays a role in circulating plasma DNA homeostasis by enhancing fragmentation and influencing end-motif frequencies. These results support a distinct role of DNASE1L3 as a regulator of the physical form and availability of cell-free DNA and may have important implications for the mechanism whereby this enzyme prevents autoimmunity.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

            The analysis of tumor-derived circulating cell-free DNA opens up new possibilities for performing liquid biopsies for the assessment of solid tumors. Although its clinical potential has been increasingly recognized, many aspects of the biological characteristics of tumor-derived cell-free DNA remain unclear. With respect to the size profile of such plasma DNA molecules, a number of studies reported the finding of increased integrity of tumor-derived plasma DNA, whereas others found evidence to suggest that plasma DNA molecules released by tumors might be shorter. Here, we performed a detailed analysis of the size profiles of plasma DNA in 90 patients with hepatocellular carcinoma, 67 with chronic hepatitis B, 36 with hepatitis B-associated cirrhosis, and 32 healthy controls. We used massively parallel sequencing to achieve plasma DNA size measurement at single-base resolution and in a genome-wide manner. Tumor-derived plasma DNA molecules were further identified with the use of chromosome arm-level z-score analysis (CAZA), which facilitated the studying of their specific size profiles. We showed that populations of aberrantly short and long DNA molecules existed in the plasma of patients with hepatocellular carcinoma. The short ones preferentially carried the tumor-associated copy number aberrations. We further showed that there were elevated amounts of plasma mitochondrial DNA in the plasma of hepatocellular carcinoma patients. Such molecules were much shorter than the nuclear DNA in plasma. These results have improved our understanding of the size profile of tumor-derived circulating cell-free DNA and might further enhance our ability to use plasma DNA as a molecular diagnostic tool.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Fragment Length of Circulating Tumor DNA

              Malignant tumors shed DNA into the circulation. The transient half-life of circulating tumor DNA (ctDNA) may afford the opportunity to diagnose, monitor recurrence, and evaluate response to therapy solely through a non-invasive blood draw. However, detecting ctDNA against the normally occurring background of cell-free DNA derived from healthy cells has proven challenging, particularly in non-metastatic solid tumors. In this study, distinct differences in fragment length size between ctDNAs and normal cell-free DNA are defined. Human ctDNA in rat plasma derived from human glioblastoma multiforme stem-like cells in the rat brain and human hepatocellular carcinoma in the rat flank were found to have a shorter principal fragment length than the background rat cell-free DNA (134–144 bp vs. 167 bp, respectively). Subsequently, a similar shift in the fragment length of ctDNA in humans with melanoma and lung cancer was identified compared to healthy controls. Comparison of fragment lengths from cell-free DNA between a melanoma patient and healthy controls found that the BRAF V600E mutant allele occurred more commonly at a shorter fragment length than the fragment length of the wild-type allele (132–145 bp vs. 165 bp, respectively). Moreover, size-selecting for shorter cell-free DNA fragment lengths substantially increased the EGFR T790M mutant allele frequency in human lung cancer. These findings provide compelling evidence that experimental or bioinformatic isolation of a specific subset of fragment lengths from cell-free DNA may improve detection of ctDNA.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                8 January 2019
                28 December 2018
                28 December 2018
                : 116
                : 2
                : 641-649
                Affiliations
                [1] aDepartment of Pathology, New York University School of Medicine , New York, NY 10016;
                [2] bLi Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong , Shatin, NT, Hong Kong SAR, China;
                [3] cDepartment of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong , Shatin, NT, Hong Kong SAR, China;
                [4] dUMR 5164 Immunologie Conceptuelle, Expérimentale et Translationnelle, ImmunoConcEpT, Université de Bordeaux , 33076 Bordeaux, France
                Author notes
                2To whom correspondence may be addressed. Email: Boris.Reizis@ 123456nyulangone.org or loym@ 123456cuhk.edu.hk .

                Contributed by Y. M. Dennis Lo, November 23, 2018 (sent for review September 13, 2018; reviewed by Michael R. Speicher and Alain R. Thierry)

                Author contributions: Y.M.D.L. initiated the study; Y.M.D.L., R.W.Y.C., L.S., and B.R. designed research; L.S., R.W.Y.C., A.R., and S.H.C. performed research; P.J., M.N., K.S., W.L., and W.P. performed bioinformatics analysis; R.W.Y.C., P.J., K.S., K.C.A.C., R.W.K.C., B.R., and Y.M.D.L. analyzed data; L.S., A.R., C.S., V.S., and B.R. generated the gene-targeted mice; and R.W.Y.C., P.J., and Y.M.D.L. wrote the paper.

                Reviewers: M.R.S., Medical University of Graz; and A.R.T., U896 INSERM, Institut Recherche en Cancérologie de Montpellier.

                1L.S. and R.W.Y.C. contributed equally to this work.

                Author information
                http://orcid.org/0000-0003-1140-7853
                http://orcid.org/0000-0001-8746-0293
                Article
                201815031
                10.1073/pnas.1815031116
                6329986
                30593563
                67fe542d-d320-44d1-8b0d-36bff5b4ef84
                Copyright © 2019 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                Page count
                Pages: 9
                Funding
                Funded by: Research Grants Council, University Grants Committee (RGC, UGC) 501100002920
                Award ID: T12-403/15-N
                Award Recipient : Peiyong Jiang Award Recipient : K.C. Allen Chan Award Recipient : Rossa W.K. Chiu Award Recipient : Y. M. Dennis Lo
                Funded by: HHS | National Institutes of Health (NIH) 100000002
                Award ID: AR071703
                Award ID: AR070591
                Award ID: GM007308 and AI100853
                Award Recipient : Boris Reizis
                Categories
                PNAS Plus
                Biological Sciences
                Medical Sciences
                PNAS Plus

                liquid biopsy,cell-free dna,noninvasive prenatal testing,systemic lupus erythematosus,cfdna

                Comments

                Comment on this article